.jpg)
Assistant Professor
Toho University Faculty of Medicine
I do not have any relevant financial / non-financial relationships with any proprietary interests.
Masaru Yanagihashi, M.D., Ph.D.
Assistant Professor
Department of Neurology
Toho University Faculty of Medicine
6-11-1 Omorinishi Ota-ku
Tokyo 143-8541 Japan
Phone: +81-3-3762-4151
________________________________________________________________________________
Education
2003-2008 M.D. in Faculty of Medicine
Toho University, Tokyo, Japan
2011-2014 Ph.D. in Department of Neurology
Graduate School of Medicine, Toho University, Tokyo,
Japan
________________________________________________________________________________
Medical Training and Professional Experiences
2009-2010 Resident in Department of Neurology
Toho University Omori Medical Center, Tokyo, Japan
2011-2012 Department of General Medicine, Kawasaki City Kawasaki Hospital, Tokyo, Japan
2015 Resident in Department of Neurology
Toho University Omori Medical Center, Tokyo, Japan
2016 Senior Resident in Department of Neurology
Toho University Faculty of Medicine, Tokyo, Japan
2019 Assistant Professor in Department of Neurology
Toho University Faculty of Medicine, Tokyo, Japan
________________________________________________________________________________
Postgraduate Training none
________________________________________________________________________________
Academic Appointments
2019 Assistant Professor in Department of Neurology
Toho University Faculty of Medicine, Tokyo, Japan
________________________________________________________________________________
Specialty Boards
Japanese Board of Internal Medicine (2013,2019)
Japanese Board of Neurology (2015)
________________________________________________________________________________
Honors and Awards none
________________________________________________________________________________
Publications
Yanagihashi M, Kawabe K, Ikeda K. Presence of paraneoplastic antibodies in non-carcinomatous patients with neurological involvements of unknown cause. J Neurol Sci. 2013 Dec 15;335(1-2):197-200.
Yanagihashi M, Kawabe K, Ikeda K:Ibudilast inhibit Th17 cell differentiation from naïve human T cells. Toho Journal of Medicine1(1):2-6,2015
Yanagihashi M, Kano O et al. Late-onset spinal form xanthomatosis without brain lesion: a case report. BMC Neurol 16:21, 2016
Yanagihashi M, Okamoto R, Morioka H, Sawada M, Matsumoto S, Ikeda T, Kano O. Coronary spastic angina after the administration of intravenous immunoglobulin in myasthenia gravis: a case report. BMC Neurol. 2020 Aug 28;20(1):319.
Yanagihashi M, Sugisawa T, Fuchimoto M, Saotome Y, Onozawa K, Matsumoto Y, Bokuda K, Ebina J, Shibukawa M, Hirayama T, Murakami Y, Washizawa N, Ebihara S, Kano O. Contradictory Responses to the COVID-19 Pandemic in Amyotrophic Lateral Sclerosis Patients and Their Families and Caregivers in Japan. Intern Med. 2021;60(10):1519-1524.
Ishikawa Y, Ikeda K, Murata K, Hirayama T, Takazawa T, Yanagihashi M, Kano O, Kawabe K, Takahashi Y, Iwasaki Y. Ophthalmoplegia and flaccid paraplegia in a patient with anti-NMDA receptor encephalitis: a case report and literature review. Intern Med. 2013;52(24):2811-5.
Ikeda K, Yanagihashi M, Hanashiro S, Sawada M, Iwasaki Y (2014) Systemic Endothelial and Arterial Changes in Migraineurs: A Review of Literature. J Neurol Disord Stroke 2(2): 1034.
Takazawa T, Ikeda K, Nagaoka T, Hirayama T, Yamamoto T, Yanagihashi M, Tochikubo T, Iwasaki Y. Wegener granulomatosis-associated optic perineuritis. Orbit. 2014 Feb;33(1):13-6.
Iwamoto K, Ikeda K, Mizumura S, Tachiki K, Yanagihashi M, Iwasaki Y. Combined treatment of methylprednisolone pulse and memantine hydrochloride prompts recovery from neurological dysfunction and cerebral hypoperfusion in carbon monoxide poisoning: a case report. J Stroke Cerebrovasc Dis. 2014 Mar;23(3):592-5.
Ikeda K, Yanagihashi M, Sawada M, Hanashiro S, Kawabe K, Iwasaki Y. Donepezil-induced cervical dystonia in Alzheimer's disease: a case report and literature review of dystonia due to cholinesterase inhibitors. Intern Med. 2014;53(9):1007-10.
Ikeda K, Sawada M, Morioka H, Kyuzen M, Ebina J, Nagasawa J, Yanagihashi M, Miura K, Ishikawa Y, Hirayama T, Takazawa T, Kano O, Kawabe K, Iwasaki Y. Clinical Profile and Changes of Serum Lipid Levels in Epileptic Patients after Cerebral Infarction. J Stroke Cerebrovasc Dis. 2017 Mar;26(3):644-649.
Ikeda K, Hanashiro S, Ishikawa Y, Sawada M, Kyuzen M, Morioka H, Ebina J, Nagasawa J, Yanagihashi M, Miura K, Hirayama T, Takazawa T, Kano O, Kawabe K, Iwasaki Y. Treatment with telmisartan, a long-acting angiotensin II receptor blocker, prevents migraine attacks in Japanese non-responders to lomerizine. Neurol Sci. 2017 May;38(5):827-831.
Ikeda K, Aoyagi J, Hanashiro S, Sawada M, Kyuzen M, Morioka H, Ebina J, Nagasawa J, Yanagihashi M, Ishikawa Y, Miura K, Murata K, Takazawa T, Kawabe K, Iwasaki Y. Preventive Treatment with Lomerizine Increases Cerebral Blood Flows during the Interictal Phase of Migraine. J Stroke Cerebrovasc Dis. 2018 Apr;27(4):998-1002.
Ikeda K, Yanagihashi M, Miura K, Ishikawa Y, Hirayama T, Takazawa T, Kano O, Kawabe K, Mizumura N, Iwasaki Y. Zonisamide cotreatment delays striatal dopamine transporter reduction in Parkinson disease: A retrospective, observational cohort study. J Neurol Sci. 2018 Aug 15;391:5-9.
Morioka H, Hirayama T, Sugisawa T, Murata K, Shibukawa M, Ebina J, Sawada M, Hanashiro S, Nagasawa J, Yanagihashi M, Uchi M, Kawabe K, Washizawa N, Ebihara S, Nakajima T, Kano O. Robot-assisted training using hybrid assistive limb ameliorates gait ability in patients with amyotrophic lateral sclerosis. J Clin Neurosci. 2022 May;99:158-163.
Morioka H, Murata K, Sugisawa T, Shibukawa M, Ebina J, Sawada M, Hanashiro S, Nagasawa J, Yanagihashi M, Hirayama T, Uchi M, Kawabe K, Ebihara S, Murakami Y, Nakajima T, Kano O. Effects of Long-term Hybrid Assistive Limb Use on Gait in Patients with Amyotrophic Lateral Sclerosis. Intern Med. 2022;61(10):1479-1484.
